anti-CD94 antibody product blog
Tags: Antibody; Monoclonal Antibody; CD94; anti-CD94 antibody;
The CD94 klrd1 (Catalog #MBS5309329) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The CD94 antibody (FITC) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s CD94 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).FC/FACS: = 0.125 ug/test
A test is defined as the amount (ug) of antibody that will stain a cell sample in a final volume of 100 ul. Cell number should be determined empirically but can range from 105 to 108 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Researchers should empirically determine the suitability of the CD94 klrd1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD94 klrd1 product has the following accession number(s) (GI #2995204) (NCBI Accession #CAA74663.1) (Uniprot Accession #Q13241). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD94 antibody (FITC) with the following immunoassay(s):
Flow Cytometry (FC/FACS) (Staining of C57Bl/6 splenocytes with NK1.1 antibody and 0.25 ug of Rat IgG2a K Isotype Control (FITC) (left) or 0.25 ug of CD94 antibody (FITC) (right). Total viable cells were used for analysis.)
The 18d3 monoclonal antibody reacts with mouse CD94, a 70 kDa type II transmembrane glycoprotein. CD94 belongs to the C-type lectin superfamily and is present as a heterodimer with NKG2 on the surface. CD94 is expressed by NK cells, a subset of T cells, and NKT cells and plays an important role in adhesion and activation of NK cell lineage. DBA/2J mice are naturally CD94-deficient and do not express cell-surface CD94/NKG2A receptors, even on neonatal NK cells.
Conjugate: FITC. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD94 are readily searchable from our website. Different antibodies against the same target such as CD94 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Cell Transformation, Neoplastic, Drug-Induced Liver Injury, Kidney Diseases, Kidney Neoplasms, Liver Diseases, Liver Neoplasms, Melanoma, Experimental, Necrosis, Urologic Neoplasms are some of the diseases may be linked to CD94 antibody (FITC).